Journal of Stem Cell Research & Therapy

Abstract

Mesenchymal Translocation- Haemosiderotic Fibrolipomatous Tumour

Anubha Bajaj

Haemosiderotic fibrohistiocytic lipomatous tumour was initially described by Marshall-Taylor and Fanburg-Smith in 2000 and is cogitated as an exceptional, biologically benign tumour emerging as a circumscribed lesion comprised of an adipose tissue and spindle-shaped cellular component with abundant haemosiderin. Heamosiderotic fibrolipomatous tumour is also designated as haemosiderotic fibrohistiocytic lipomatous tumour and is contemplated as an equivalent to a preliminary lesion of pleomorphic hyalinising angiectactic tumour. Haemosiderotic fibrolipomatous tumour is categorized within fibrous lesions and is denominated as a locally aggressive neoplasm incriminating subcutaneous tissue and is devoid of distant metastasis. Haemosiderotic fibrolipomatous tumour is a translocation- associated mesenchymal tumour with a distinctive histology constituted by fibroblast- like, spindle-shaped cells, mature adipocytes and hemosiderin deposits.

Published Date: 2021-02-27; Received Date: 2021-02-04